PMID- 29126878 OWN - NLM STAT- MEDLINE DCOM- 20190128 LR - 20190128 IS - 1879-0542 (Electronic) IS - 0165-2478 (Linking) VI - 195 DP - 2018 Mar TI - Dendritic cells in systemic sclerosis: Advances from human and mice studies. PG - 18-29 LID - S0165-2478(17)30290-0 [pii] LID - 10.1016/j.imlet.2017.11.003 [doi] AB - Systemic sclerosis (SSc) is a complex heterogeneous fibrotic autoimmune disease with an unknown exact etiology, and characterized by three hallmarks: fibrosis, vasculopathy, and immune dysfunction. Dendritic cells (DCs) are specialized cells in pathogen sensing with high potency of antigen presentation and capable of releasing mediators to shape the immune response. Altered DCs distributions and their impaired functions may account for their role in breaking the immune tolerance and driving inflammation in SSc, and the direct contribution of DCs in promoting endothelial dysfunction and fibrotic process has only begun to be understood. Plasmacytoid dendritic cells in particular have been implicated due to their high production of type I interferon as well as other cytokines and chemokines, including the pro-inflammatory and anti-angiogenic CXCL4. Furthermore, a deeper understanding of human and mouse DC biology has clarified their identification and function in different tissues, and novel DC subsets have only recently been discovered. In this review, we highlight key findings and recent advances exploring DC role in the pathogenesis of SSc and other related autoimmune diseases, and consideration of their potential use as targeted therapy in SSc. CI - Copyright (c) 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved. FAU - Affandi, Alsya J AU - Affandi AJ AD - Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. FAU - Carvalheiro, Tiago AU - Carvalheiro T AD - Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. FAU - Radstake, Timothy R D J AU - Radstake TRDJ AD - Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. FAU - Marut, Wioleta AU - Marut W AD - Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Electronic address: W.K.Marut@umcutrecht.nl. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20171107 PL - Netherlands TA - Immunol Lett JT - Immunology letters JID - 7910006 RN - 37270-94-3 (Platelet Factor 4) SB - IM MH - Animals MH - Antigen Presentation MH - Cell Differentiation MH - Dendritic Cells/*immunology MH - Humans MH - Inflammation/*immunology MH - Mice MH - Models, Animal MH - Platelet Factor 4/metabolism MH - Scleroderma, Systemic/*immunology OTO - NOTNLM OT - Dendritic cells OT - Fibrosis OT - Inflammation OT - Pathogenesis OT - Systemic sclerosis EDAT- 2017/11/12 06:00 MHDA- 2019/01/29 06:00 CRDT- 2017/11/12 06:00 PHST- 2017/06/21 00:00 [received] PHST- 2017/11/05 00:00 [revised] PHST- 2017/11/06 00:00 [accepted] PHST- 2017/11/12 06:00 [pubmed] PHST- 2019/01/29 06:00 [medline] PHST- 2017/11/12 06:00 [entrez] AID - S0165-2478(17)30290-0 [pii] AID - 10.1016/j.imlet.2017.11.003 [doi] PST - ppublish SO - Immunol Lett. 2018 Mar;195:18-29. doi: 10.1016/j.imlet.2017.11.003. Epub 2017 Nov 7.